Cargando…
Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study
BACKGROUND: Though infections are associated with psychotic symptoms, whether or not subclinical inflammation is associated with hallucinations is not known in Parkinson’s disease (PD). PURPOSE: To investigate the association of illusions/hallucinations and plasma CRP levels in PD patients without s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908859/ https://www.ncbi.nlm.nih.gov/pubmed/24497930 http://dx.doi.org/10.1371/journal.pone.0085886 |
_version_ | 1782301756956344320 |
---|---|
author | Sawada, Hideyuki Oeda, Tomoko Umemura, Atsushi Tomita, Satoshi Hayashi, Ryutaro Kohsaka, Masayuki Yamamoto, Kenji Sudoh, Shinji Sugiyama, Hiroshi |
author_facet | Sawada, Hideyuki Oeda, Tomoko Umemura, Atsushi Tomita, Satoshi Hayashi, Ryutaro Kohsaka, Masayuki Yamamoto, Kenji Sudoh, Shinji Sugiyama, Hiroshi |
author_sort | Sawada, Hideyuki |
collection | PubMed |
description | BACKGROUND: Though infections are associated with psychotic symptoms, whether or not subclinical inflammation is associated with hallucinations is not known in Parkinson’s disease (PD). PURPOSE: To investigate the association of illusions/hallucinations and plasma CRP levels in PD patients without symptomatic infections. METHODS: PD patients not diagnosed as having infections were assessed for illusions and hallucinations using the Parkinson Psychosis Questionnaire (PPQ). It comprises four-domain questions: PPQ-A for sleep problems, PPQ-B for hallucinations/illusions, PPQ-C for delusions, and PPQ-D for disorientation. Assigning patients with ≥1 points in the PPQ-B score to be cases and others as controls, the association of hallucinations/illusions and clinical features (age, sex, duration of PD, Unified Parkinson’s Disease Rating Scale part 3 (UPDRS-3), Mini-Mental State Examination (MMSE) score, sleep disturbance (PPQ-A score) as well as daily doses of L-Dopa, dopamine agonists, amantadine, and selegiline) were analyzed using a case–control design. RESULTS: A total of 111 patients were examined and plasma CRP levels were <0.1–6.0 mg/L. Hallucinations or illusions were detected in 28 (25.2%). There were significant differences in age, UPDRS-3 score, MMSE score, PPQ-A, daily doses of L-Dopa and dopamine agonists and plasma CRP levels between cases and controls. A multivariate logistic regression model revealed that UPDRS-3 scores and plasma CRP levels were significantly associated with hallucinations/illusions with an adjusted odds ratio of 1.96 (95% confidence interval (CI) 1.20–3.20) per 10 points and 1.57 (95% confidence interval 1.13–2.16) per two-fold, respectively. Dividing patients into thirds by CRP levels (≤0.2, 0.3–0.6, ≥0.7 mg/L), the prevalence of hallucinations/illusions was 13.2%, 21.6%, and 41.7%, in the bottom-, middle-, and top-thirds, respectively (for trend p = 0.012). CONCLUSIONS: Subclinical elevation of plasma CRP levels was associated with hallucinations or illusions after adjustment for motor disability, suggesting that subclinical elevations of CRP levels might be an independent risk for hallucinations/illusions. |
format | Online Article Text |
id | pubmed-3908859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39088592014-02-04 Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study Sawada, Hideyuki Oeda, Tomoko Umemura, Atsushi Tomita, Satoshi Hayashi, Ryutaro Kohsaka, Masayuki Yamamoto, Kenji Sudoh, Shinji Sugiyama, Hiroshi PLoS One Research Article BACKGROUND: Though infections are associated with psychotic symptoms, whether or not subclinical inflammation is associated with hallucinations is not known in Parkinson’s disease (PD). PURPOSE: To investigate the association of illusions/hallucinations and plasma CRP levels in PD patients without symptomatic infections. METHODS: PD patients not diagnosed as having infections were assessed for illusions and hallucinations using the Parkinson Psychosis Questionnaire (PPQ). It comprises four-domain questions: PPQ-A for sleep problems, PPQ-B for hallucinations/illusions, PPQ-C for delusions, and PPQ-D for disorientation. Assigning patients with ≥1 points in the PPQ-B score to be cases and others as controls, the association of hallucinations/illusions and clinical features (age, sex, duration of PD, Unified Parkinson’s Disease Rating Scale part 3 (UPDRS-3), Mini-Mental State Examination (MMSE) score, sleep disturbance (PPQ-A score) as well as daily doses of L-Dopa, dopamine agonists, amantadine, and selegiline) were analyzed using a case–control design. RESULTS: A total of 111 patients were examined and plasma CRP levels were <0.1–6.0 mg/L. Hallucinations or illusions were detected in 28 (25.2%). There were significant differences in age, UPDRS-3 score, MMSE score, PPQ-A, daily doses of L-Dopa and dopamine agonists and plasma CRP levels between cases and controls. A multivariate logistic regression model revealed that UPDRS-3 scores and plasma CRP levels were significantly associated with hallucinations/illusions with an adjusted odds ratio of 1.96 (95% confidence interval (CI) 1.20–3.20) per 10 points and 1.57 (95% confidence interval 1.13–2.16) per two-fold, respectively. Dividing patients into thirds by CRP levels (≤0.2, 0.3–0.6, ≥0.7 mg/L), the prevalence of hallucinations/illusions was 13.2%, 21.6%, and 41.7%, in the bottom-, middle-, and top-thirds, respectively (for trend p = 0.012). CONCLUSIONS: Subclinical elevation of plasma CRP levels was associated with hallucinations or illusions after adjustment for motor disability, suggesting that subclinical elevations of CRP levels might be an independent risk for hallucinations/illusions. Public Library of Science 2014-01-31 /pmc/articles/PMC3908859/ /pubmed/24497930 http://dx.doi.org/10.1371/journal.pone.0085886 Text en © 2014 Sawada et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sawada, Hideyuki Oeda, Tomoko Umemura, Atsushi Tomita, Satoshi Hayashi, Ryutaro Kohsaka, Masayuki Yamamoto, Kenji Sudoh, Shinji Sugiyama, Hiroshi Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study |
title | Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study |
title_full | Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study |
title_fullStr | Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study |
title_full_unstemmed | Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study |
title_short | Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study |
title_sort | subclinical elevation of plasma c-reactive protein and illusions/hallucinations in subjects with parkinson’s disease: case–control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908859/ https://www.ncbi.nlm.nih.gov/pubmed/24497930 http://dx.doi.org/10.1371/journal.pone.0085886 |
work_keys_str_mv | AT sawadahideyuki subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT oedatomoko subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT umemuraatsushi subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT tomitasatoshi subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT hayashiryutaro subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT kohsakamasayuki subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT yamamotokenji subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT sudohshinji subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy AT sugiyamahiroshi subclinicalelevationofplasmacreactiveproteinandillusionshallucinationsinsubjectswithparkinsonsdiseasecasecontrolstudy |